Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1973 May;27(5):396–399. doi: 10.1038/bjc.1973.47

Cyclophosphamide and Nandrolone Decanoate in the Treatment of Advanced Carcinoma of the Breast—Results of a Comparative Controlled Trial of the Agents Used Singly and in Combination

M P Cole, I D H Todd, P M Wilkinson
PMCID: PMC2008797  PMID: 4576562

Abstract

A random trial in which cyclophosphamide, nandrolone decanoate and the two drugs in combination were used in the treatment of advanced breast carcinoma is described. The results suggest that it is preferable to use cyclophosphamide on its own.

Full text

PDF
396

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brock N., Gross R., Hohorst H. J., Klein H. O., Schneider B. Activation of cyclophosphamide in man and animals. Cancer. 1971 Jun;27(6):1512–1529. doi: 10.1002/1097-0142(197106)27:6<1512::aid-cncr2820270636>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  2. Hayakawa T., Kanai N., Yamada R., Kuroda R., Higashi H., Mogami H., Jinnai D. Effect of steroid hormone on activation of Endoxan (cyclophosphamide). Biochem Pharmacol. 1969 Jan;18(1):129–135. doi: 10.1016/0006-2952(69)90017-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES